Dr Bryan & Dr. McGee discuss NOviricid Therapeutic Clinical Trial for African Americans w/Covid-19

Dr. Nathan S. Bryan, Founder and CEO of Nitric Oxide Innovations, and Dr. Michael A. McGee, an Emergency Room Care Physician, Managing Partner and CEO of Premier Urgent Care in South Side Hyde Park, the clinical medical site for Chicago, Illinois discuss the first Oral Systemic Nitric Oxide Based Therapeutic specifically for African Americans with early COVID-19. Cleared for clinical trials.
For Clinical Trial information: www.AACovidStudy.com
For More Study information:
Dr. Bryan: [email protected]
Dr. McGee: www.premierucchicago.com
For More on NOviricid: www.nitricoxideinnovations.com